Find participating medical centers and current study status in each of them

    Find participating medical centers

    A Phase 1, Open-label, Single-dose Study to Evaluate the Effect of Moderate or Severe Renal Impairment on the Pharmacokinetics of Inavolisib

    • Kidney Disorder
    • Renal Failure
    • Healthy Volunteers